[HTML][HTML] The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart… - The Journal of …, 2013 - Am Soc Clin Investig
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
[PDF][PDF] The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart, J Deguine… - researchgate.net
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart… - Journal of Clinical …, 2013 - search.proquest.com
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
[引用][C] The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart… - Journal of Clinical …, 2013 - cir.nii.ac.jp
The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging.
F Montalvao, Z Garcia, S Celli, B Breart… - The Journal of …, 2013 - europepmc.org
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart… - Journal of Clinical …, 2013 - hal.science
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
[HTML][HTML] The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart… - The Journal of …, 2013 - ncbi.nlm.nih.gov
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart… - Journal of Clinical …, 2013 - pasteur.hal.science
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
The mechanism of anti-CD20--mediated B cell depletion revealed by intravital imaging.
F Montalvao, Z Garcia, S Celli, B Breart… - Journal of Clinical …, 2013 - search.ebscohost.com
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
[PDF][PDF] The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
F Montalvao, Z Garcia, S Celli, B Breart, J Deguine… - Am Soc Clin Investig
Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …
of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell …